Therefore, increased accessibility of the endogenous TLR3 protein agonist stathmin in myelin debris combined with the prolonged presence of fibronectin, increases the change of a double hit, likely resulting in fibronectin aggregation in MS lesions. The gene discussed is TLR3; the disease is myeloid sarcoma.